An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Phase of Trial: Phase II
Latest Information Update: 01 May 2019
Price : $35 *
At a glance
- Drugs Abatacept (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 27 Mar 2018 Status changed from active, no longer recruiting to completed.
- 27 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 27 Oct 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.